![](https://connectedhealthandfitness.com/sites/default/files/styles/panopoly_image_square/public/speakers/kerry_briggs.jpeg?itok=Xt0hGrES&c=1469a91dfe921bb4e875663f09d80bd6)
Kerry Briggs
![](https://connectedhealthandfitness.com/sites/default/files/styles/panopoly_image_square/public/speakers/matthieu.jpg?itok=AnAU2MP4&c=6dba7b88948980fbbbcf03bfaa1af0ab)
Matthieu Vallin
Matthieu Vallin joined Octopus Ventures in 2020 and focuses on sourcing and qualifying early-stage investments that will transform healthcare and life sciences. From consumer health through to advances in drug discovery, he liaises with entrepreneurs who have a drive to bring the most benefits to the delivery of care and patient outcomes.
![](https://connectedhealthandfitness.com/sites/default/files/styles/panopoly_image_square/public/speakers/eileen_buttimer-040_550x550.jpg?itok=spQaYtLj&c=31cbcc2ebb343dc2d7add6f2eb58ee31)
Eileen Buttimer
Eileen Buttimer is Senior Vice President of New Business Development at Sagentia Innovation and has over 20 years’ experience exploring innovation opportunities with clients across multiple sectors including consumer health, pharma and med tech. She is particularly passionate about driving innovation in the Women’s Health space. Eileen is a strong professional skilled in International Business, Innovation Management, Entrepreneurship and Market Analysis. She holds a PhD in Biochemistry and an MBA and prior to Sagentia Innovation, she has held R&D management positions in DuPont and Pfizer.
![](https://connectedhealthandfitness.com/sites/default/files/styles/panopoly_image_square/public/speakers/gesser_avi_lo.jpg?itok=qkhvfOT_&c=7a57dfcd5a11273928b86ce6209122b7)
Avi Gesser
![](https://connectedhealthandfitness.com/sites/default/files/styles/panopoly_image_square/public/speakers/shannon.jpg?itok=BYiZ5BLR&c=6492480eeb98cfd93f35ba696a64a2f3)
Shannon Altimari
Shannon joined GSK in 2020 as the company’s Global Head of Oncology Advocacy to Outcomes. In this role, she leads GSK’s oncology patient advocacy strategies, with a focus on improving outcomes and supporting equitable access for patients. Prior to GSK, she was with TESARO Bio GmbH as Head of International Corporate Affairs. Before TESARO, she spent 10 years with Biogen. She is an American citizen currently living in Switzerland.
![](https://connectedhealthandfitness.com/sites/default/files/styles/panopoly_image_square/public/speakers/shannon.jpg?itok=BYiZ5BLR&c=6492480eeb98cfd93f35ba696a64a2f3)
Shannon Altimari
Shannon joined GSK in 2020 as the company’s Global Head of Oncology Advocacy to Outcomes. In this role, she leads GSK’s oncology patient advocacy strategies, with a focus on improving outcomes and supporting equitable access for patients. Prior to GSK, she was with TESARO Bio GmbH as Head of International Corporate Affairs. Before TESARO, she spent 10 years with Biogen. She is an American citizen currently living in Switzerland.
![](https://connectedhealthandfitness.com/sites/default/files/styles/panopoly_image_square/public/speakers/pilar_femtech_at_mas_headshot.jpg?itok=i-Hh5abj&c=323f6b4032102b5ac81b569e775c95c3)
Maria del Pilar Diaz Gonzalez
Pilar is a global and multi-cultural business senior executive with 20+ years of experience in the consumer goods industry. She started her career in Spain where she is originally from, and later spanning multiple geographic locations across USA, Italy, Portugal, Switzerland and Germany. She built her career with a focus on Strategy, Marketing, Innovation and Commercialization. Pilar is currently the CEO at FemTech at MAS Holdings, the largest and leading design-to-delivery apparel solutions provider in South Asia. In her own words, she is "passionate about helping shape the future of FemHealth, an industry with massive growth potential that has been long neglected. Very proud to work with people who dare to break the taboos surrounding female intimate health and wellness, and support women through the ups and downs, the glory, and the pain, of every stage in their lives